HCV Special Populations and Other Highlights

November 7-11, 2014; Boston, Massachusetts
In this expert analysis, Jordan J. Feld, MD, MPH; Paul Y. Kwo, MD; and Stefan Zeuzem, MD, discuss the most clinically relevant data on the management of hepatitis C infection in patients with advanced liver disease, cirrhosis, liver transplantation, and HIV coinfection, as well as new advances in the treatment of hepatitis D infection.
Jordan J. Feld, MD, MPH
Paul Y. Kwo, MD
Stefan Zeuzem, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Released: February 10, 2015 Expiration: February 9, 2016

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Integrate the results of recent clinical studies of approved HCV therapies into management strategies for patients with advanced liver disease
  • Evaluate the impact of results of clinical studies of investigational treatments for chronic hepatitis C on future patient management strategies for patients with liver transplantation
  • Incorporate recent clinical trial results into patient care strategies for HCV/HIV coinfection
  • Evaluate the impact of results of clinical studies of investigational treatments for hepatitis D on future patient management strategies

Acknowledgements

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Produced in collaboration with
Educational grant provided by:
AbbVie
Gilead Sciences
Janssen Therapeutics

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Jordan J. Feld, MD, MPH

Assistant Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Diseases
Sandra Rotman Centre for Global Health
Toronto, Ontario, Canada

Jordan J. Feld, MD, MPH, has disclosed that he has received funds for research support from AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen and Merck and consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Merck.
Paul Y. Kwo, MD

Professor of Medicine
Medical Director of Transplantation
Division of Medicine/Gastroenterology/Hepatology
Indiana University School of Medicine
Indianapolis, Indiana

Paul Y. Kwo, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Merck; funds for research support from AbbVie, Bristol-Myers Squibb, Conatus, Gilead Sciences, Janssen, and Merck.
Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck.

Staff

Edward King, MA

Chief Innovation Officer

Edward King, MA, has no real or apparent conflicts of interest to disclose.
Krista Marcello

Associate Managing Editor

Krista Marcello has no real or apparent conflicts of interest to disclose.
Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no real or apparent conflicts of interest to disclose.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no real or apparent conflicts of interest to disclose.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz has no real or apparent conflicts of interest to disclose.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education, Debbie Price, Database Administrative Secretary, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians and other healthcare professionals involved in the care of patients with liver disease.

Goal

The goal of this program is to identify the most clinically significant data from AASLD 2014 and translate those data to management strategies for patients with liver disease.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 10, 2015, through February 09, 2016:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Downloadable slideset from Clinical Care Options on key aspects of HCV pharmacy service provision, with insights from expert faculty

John Faragon, PharmD, BCPS, AAHIVP
Program Director
Michelle T. Martin, PharmD, FCCP, BCPS, BCACP
Released: February 4, 2019

Expert commentary from Dr. Susanna Naggie on how to manage drug–drug interactions between ART and HCV regimens during HCV/HIV coinfection.

Susanna Naggie, MD, MHS Released: January 25, 2019

Find out what pharmacists can do to expand and improve HCV service provision in this interactive CME/CPE module from Clinical Care Options

John Faragon, PharmD, BCPS, AAHIVP
Program Director
Aileen Chi, PharmD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Pharmacists: 0.75 contact hours (0.075 CEUs) Released: January 11, 2019 Expiration: January 10, 2020

Downloadable slideset from Clinical Care Options on key aspects of HCV pharmacy service provision, with insights from Aileen Chi, PharmD

Aileen Chi, PharmD Released: January 11, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?